Stephen Lemieux

All filings by Stephen Lemieux on record concern Edesa Biotech, Inc. Over a trading history stretching from 15 July 2023 to 20 March 2026, the count stands at 6 filings.

Sales make up the whole of the open-market record (2 sales, €121k). The rest of the record consists of 2 option exercises. 2026 to date brings no purchases and 2 sales.

The newest entry dates from 23 March 2026: an option exercise, in Edesa Biotech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 11 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.